Who We Are
Aviorion is an organization that operates in the pharmaceutical and OTC industry, specializing in the research, development, production, marketing, and distribution of pharmaceutical drugs and medications. These companies play a crucial role in the healthcare sector, as they are responsible for discovering and bringing new medications to the market, improving existing drugs, and addressing various medical conditions and diseases.
Key Aspects
Research and Development (R&D): Aviorion invest heavily in research and development to discover and develop new drugs. This process involves identifying potential drug targets, conducting preclinical studies, and carrying out extensive clinical trials to assess the safety and efficacy of the drugs.
Drug Manufacturing: Once a drug has successfully passed clinical trials and obtained regulatory approval, company undertake large-scale manufacturing to produce the medication in sufficient quantities to meet market demand.
Marketing and Sales: Marketing and sales teams to promote their medications to healthcare professionals, hospitals, clinics, Retailers and pharmacies. They also engage in direct-to-consumer advertising to raise awareness about their products.
Regulatory Compliance: Complying with stringent regulations and standards set by health authorities. We meet safety, quality, and efficacy requirements before drugs can be approved and distributed.
Intellectual Property: Secure patents for their new drugs, granting them exclusive rights to manufacture and sell the medication for a certain period. This helps them recoup the significant investment made during drug development.
Generics: In addition to developing new drugs, Aviorion produce generic versions of existing medications once the original patent has expired. Generics provide more affordable options for patients and healthcare systems.
Collaborations and Partnerships: Collaboration with academic institutions, research organizations, and other pharmaceutical companies is common in the industry. Such partnerships facilitate knowledge exchange, research funding, and joint efforts in drug development.
Pharmacovigilance: We have robust pharmacovigilance systems in place to monitor and report any adverse effects or safety concerns related to their medications.